This information was published on 2026-10-26T16:31:03 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2707125 |
| (220) |
20 Oct 2026
|
| (300) |
US, 28 Apr 2026, 99791630
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the treatment of autoimmune, inflammatory, and immune-mediated diseases and disorders; Pharmaceutical preparations for the treatment of diseases and conditions of the immune system; Pharmaceutical preparations for the treatment of Sjögren’s syndrome and related conditions; Pharmaceutical preparations for the treatment of dryness of the eyes and mouth; Pharmaceutical preparations. |
| (540) | RYSEZRA |
| (550) | Word |
| (730) |
Viela Bio, Inc.
|
| (750) |
Spruson & Ferguson
|
Find out more about publications on the About page.